期刊
CANCER RESEARCH
卷 69, 期 14, 页码 5927-5935出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-08-4786
关键词
-
类别
资金
- Ministry of Education, Science and Culture of Japan
- Sumitomo Foundation
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Astellas Foundation for Research on Metabolic Disorders
- Life Science Foundation of Japan
- Uehara Memorial Foundation
- Cell Science Research Foundation
- Senri Life Science Foundation
Nuclear factor-kappa B (NF-kappa B) is tightly modulated by I kappa B kinases and I kappa B alpha in the cytoplasm. On stimulation, NF-kappa B translocates into the nucleus to initiate transcription; however, regulation of its transcriptional activity remains obscure. Here, we show that protein kinase C (PKC) delta controls the main subunit of NF-kappa B, RelA/p65. On exposure to tumor necrosis factor-alpha (TNF-alpha), the expression of RelA/p65 target genes such as I kappa B alpha, RelB, and p100/p52 is upregulated in a PKC delta-dependent manner. The results also show that PKC delta is targeted to the nucleus and forms a complex with RelA/p65 following TNF-alpha exposure. Importantly, kinase activity of PKC delta is required for RelA/p65 transactivation. In concert with these results, PKC delta activates RelA/p65 for its occupancy to target-gene promoters, including I kappa B alpha and p100/p52. Moreover, functional analyses show that inhibition of PKC delta is associated with substantial attenuation of NF-kappa B activity in response to TNF-alpha. These findings provide evidence that PKC delta orchestrates RelA/p65 transactivation, a requisite for NF-kappa B signaling pathway in the nucleus. [Cancer Res 2009;69(14):5927-35]
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据